TScan Therapeutics appoints Nicholson to board of directors, Biggar as Chair
PremiumThe FlyTScan Therapeutics appoints Nicholson to board of directors, Biggar as Chair
5M ago
TScan Therapeutics receives FDA’s RMAT designation for two TCR-T candidates
Premium
The Fly
TScan Therapeutics receives FDA’s RMAT designation for two TCR-T candidates
6M ago
TScan Therapeutics initiated with a Buy at BTIG
Premium
The Fly
TScan Therapeutics initiated with a Buy at BTIG
6M ago
TScan Therapeutics 2.473M share Spot Secondary priced at $7.13
PremiumThe FlyTScan Therapeutics 2.473M share Spot Secondary priced at $7.13
7M ago
TScan Therapeutics Advances in Solid and Hematological Cancer Therapy
Premium
Company Announcements
TScan Therapeutics Advances in Solid and Hematological Cancer Therapy
7M ago
TScan Therapeutics announces $125M common stock offering
Premium
The Fly
TScan Therapeutics announces $125M common stock offering
7M ago
Tscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
PremiumPre-EarningsTscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
8M ago
TScan Therapeutics presents Phase 1 clinical results on TSC-100, TSC-101
Premium
The Fly
TScan Therapeutics presents Phase 1 clinical results on TSC-100, TSC-101
9M ago
TScan to host virtual KOL event to discuss Phase 1 heme malignancies study
Premium
The Fly
TScan to host virtual KOL event to discuss Phase 1 heme malignancies study
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100